Facilities We've Transformed
From among Thailand's first cannabis exports to large-scale pharmaceutical production. Evergreen Medica designs, builds, and operates export-grade indoor facilities, and consults for those building their own. Every system we deploy is one we run in our own facility first.
A top-tier pharmaceutical-grade indoor cultivation facility powered by our own proprietary genetics, engineered against a target of under $0.50 per gram while meeting international medical standards. Paired with a fully integrated EU-GMP processing facility on site. Every system in the design is already running in one of the 10 facilities we have built or rebuilt.
Our genetic library is a core production asset: 60+ cultivars bred and selected for rich terpene profiles, targeted cannabinoid ratios, and compliance-ready chemistry. These genetics power our own production and are available to select partners through consulting engagements.
Established international buyer demand across AU, UK, and DE markets.
From our own proof-of-concept exports to full operational transformations for licensed producers. Every facility runs on Evergreen genetics and systems.
Beyond our flagship transformations, Evergreen has provided targeted consulting, genetics deployment, and production guidance to operators across Canada and Southeast Asia.
Plus three additional advisory engagements under NDA.
We've taken facilities from zero production to international exports in under 6 months. Whether you're starting from scratch or turning around a struggling operation, the systems are proven.
Everything we've built in our own operations (the genetics, the systems, the compliance frameworks) is available as a consulting engagement. We run these systems in our own facility, then deploy the same ones in yours.
Select partners receive access to Evergreen Medica's proprietary genetics library.
Every engagement begins with a site visit. What comes next depends on what your facility needs.
Leadership team scaling export-grade cultivation systems across international markets, combining proprietary genetics, operational systems, and repeatable, compliance-driven execution.
By vegging plants in place inside the flower room, facilities can eliminate non-productive square footage and convert veg space into additional flower capacity.
11 key cloning recommendations from 30+ years of cultivation experience. Prep mothers in advance, manage humidity carefully, and keep light low.
Stable temperature, humidity in range, VPD dialed. But surface-level environmental metrics aren't enough. You need to look deeper at canopy-level variations.
Common questions from licensed producers, investors, and buyers exploring pharmaceutical-grade cannabis production in Thailand and internationally.
Whether you're an investor, a licensed producer looking for consulting, or a buyer seeking pharmaceutical-grade supply, we'd like to hear from you. Every conversation starts with no obligation.
